コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ), function as transcriptional activators of Moloney murine leukemia virus.
2 ysis of 639 nucleotides in the gag region of Moloney murine leukemia virus.
3 man immunodeficiency virus type 1 (HIV-1) or Moloney murine leukemia virus.
4 long terminal repeat (LTR) sequences of the Moloney murine leukemia virus.
5 ed by ts1, a temperature-sensitive mutant of Moloney murine leukemia virus.
6 of the dimerization and packaging domain of Moloney murine leukemia virus.
7 tants of Hrs had no effect on the release of Moloney murine leukemia virus.
8 eracting with the capsid (CA) protein of the Moloney murine leukemia virus.
9 elet-derived growth factor (PDGF)-containing Moloney murine leukemia viruses.
11 e kinase PIM1 (Proviral Integration site for Moloney murine leukemia virus 1) has emerged as a key re
12 pendent kinase proviral integration site for Moloney murine leukemia virus-1 (PIM-1), which in turn r
13 oplasmic domain derived from the amphotropic Moloney murine leukemia virus 4070A GP, revealed about 1
16 n cells expressing envelope protein (Env) of Moloney murine leukemia virus and target cells were stud
17 ) genes were generated between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A
18 pseudotyped virus with a genome based on the Moloney murine leukemia virus and the envelope protein o
19 (Pro) primer for (-) strand DNA synthesis of Moloney murine leukemia virus and the first five residue
20 able to gene delivery by wild-type ecotropic Moloney murine leukemia virus and vesicular stomatitis v
21 immunodeficiency virus, HIV type 2 (HIV-2), Moloney murine leukemia virus, and avian myeloblastosis
22 riptases tested (avian myeloblastosis virus, Moloney murine leukemia virus, and human immunodeficienc
24 -dependent manner and enhanced expression of Moloney murine leukemia virus- and murine embryonic stem
25 ces between XMRV and the intensively studied Moloney murine leukemia virus, architectures of the regu
26 l helper virus, pAM3-IRES-Zeo, that contains Moloney murine leukemia virus as a helper virus and a pi
27 mate lentiviruses and distinct from those of Moloney murine leukemia virus, avian sarcoma leukosis vi
28 evere combined immunodeficiency (SCID-X1), a Moloney murine leukemia virus-based gamma-retrovirus vec
29 atal mice were injected intravenously with a Moloney murine leukemia virus-based retroviral vector (R
32 in transduction efficiency by both HIV- and Moloney murine leukemia virus-based retroviral vectors.
37 HIV-1 replication than cells transduced with Moloney murine leukemia virus-based vectors expressing T
38 te dehydrogenase (hG6PD) gene transferred by Moloney murine leukemia virus-based vectors into murine
41 ssive cis-acting DNA sequences identified in Moloney murine leukemia virus but remains sensitive to t
42 retrovirus, MoFe2, or with the parent virus, Moloney murine leukemia virus, caused significant reduct
45 e full length, positive-strand genome of the Moloney Murine Leukemia Virus contains a "core encapsida
46 sults also suggest that the leader region of Moloney murine leukemia virus contains inhibitory/regula
48 ation, followed by reverse transcription via Moloney murine leukemia virus, degradation of chromosoma
49 deletion of sequences in the 3' U3 region of Moloney murine leukemia virus-derived retroviral vectors
50 lular protein that blocks autointegration of Moloney murine leukemia virus DNA, also plays an indirec
52 erived MLE-15 cells infected with a chimeric Moloney murine leukemia virus driven by the JSRV enhance
55 l receptor-binding sequence of the ecotropic Moloney murine leukemia virus envelope glycoprotein with
56 acids within the receptor-binding domain of Moloney murine leukemia virus envelope in order to ident
57 we have studied how the protomeric units of Moloney murine leukemia virus envelope protein (Env) are
58 e we report that tryptophan 142 in ecotropic Moloney murine leukemia virus envelope protein is essent
62 s between transmembrane proteins (TM) of the Moloney murine leukemia virus envelope using the Sacchar
63 occus nuclease (SN) to the C-terminal end of Moloney murine leukemia virus Gag and demonstrated that
64 trovirus packaging cell lines expressing the Moloney murine leukemia virus gag and pol genes but lack
65 Retroviral genomes encoding a portion of the Moloney murine leukemia virus Gag protein fused to porti
67 by eight footprints representing regions of Moloney murine leukemia virus gag, some previously uncha
68 dful" was tested by examining the ability of Moloney murine leukemia virus genomes lengthened by 4, 8
69 coated with the parental wild-type ecotropic Moloney murine leukemia virus glycoprotein through the e
70 es were not detected either to Rev M10 or to Moloney murine leukemia virus gp70 envelope protein.
71 me suppression of the gag gene stop codon in Moloney murine leukemia virus has been studied by UV hyp
72 al analyses of the p12 Gag phosphoprotein of Moloney murine leukemia virus have demonstrated its part
74 nuclear magnetic resonance structure of the Moloney murine leukemia virus IN (M-MLV) C-terminal doma
76 have previously described a mutant RT of the Moloney murine leukemia virus in which F155 was replaced
77 To study the function of the HHCC domain of Moloney murine leukemia virus IN, the first N-terminal 1
78 roduced by the Gag polyproteins of HIV-1 and Moloney murine leukemia virus, indicating that no specif
79 oncogene associated with the progression of Moloney murine leukemia virus-induced T cell lymphomas i
80 viral nucleoprotein complexes isolated from Moloney murine leukemia virus-infected cells exhibit a b
81 receptor-5-positive (Lgr5(+)) and B lymphoma moloney murine leukemia virus insertion region homolog-1
83 rabidopsis (Arabidopsis thaliana) B lymphoma Moloney murine leukemia virus insertion region1 homolog
85 e examine the role of Bmi-1 (B-cell-specific Moloney murine leukemia virus integration site 1) as a r
89 igh expression of proviral insertion site of Moloney murine leukemia virus kinases (Pim-1, -2, and -3
92 tomegalovirus enhancer-promoter fused to the Moloney murine leukemia virus long terminal repeat at th
93 r and enhancer] or an intermediate strength (Moloney murine leukemia virus long terminal repeat) prom
94 ng hybrid duplex substrates derived from the Moloney murine leukemia virus long terminal repeat, we i
95 internal grp78 promoter, in contrast to the Moloney murine leukemia virus long terminal repeat, wher
96 xpression in vivo from vectors driven by the Moloney murine leukemia virus long-terminal repeat (LTR)
97 expressing the antisense RNAs as part of the Moloney murine leukemia virus LTR promoter-directed retr
98 repeat (LTR) was found to be higher than the Moloney murine leukemia virus LTRs in both LNCaP and WPM
100 mbinant avian myeloblastosis virus (AMV) and Moloney murine leukemia virus (M-MLV) reverse transcript
102 substrates and the reverse transcriptases of Moloney murine leukemia virus (M-MuLV) and human immunod
103 t structural studies have suggested that the Moloney murine leukemia virus (M-MuLV) CA protein may as
104 ane-bound arrays of an N-terminal His-tagged Moloney murine leukemia virus (M-MuLV) capsid (CA) prote
105 ly stained, membrane-bound, histidine-tagged Moloney murine leukemia virus (M-MuLV) capsid protein (h
107 uctural motifs located in the 5' part of the Moloney murine leukemia virus (M-MuLV) encapsidation dom
108 s shown that gPr80gag facilitates release of Moloney murine leukemia virus (M-MuLV) from cells along
112 wo-end integration reaction catalyzed by the Moloney murine leukemia virus (M-MuLV) integrase (IN) wa
116 nces within terminal inverted repeats of the Moloney murine leukemia virus (M-MuLV) LTR were synthesi
117 system that mimics the assembly of immature Moloney murine leukemia virus (M-MuLV) particles to exam
118 were generated within the 3' terminus of the Moloney murine leukemia virus (M-MuLV) pol gene encoding
119 re involved in the specific encapsidation of Moloney murine leukemia virus (M-MuLV) RNA into M-MuLV v
121 A chimera between Ty3 and a Neo(r)-marked Moloney murine leukemia virus (M-MuLV) was constructed.
123 or function of the integrase (IN) protein of Moloney murine leukemia virus (M-MuLV) were investigated
124 an immunodeficiency virus type 1 (HIV-1) and Moloney murine leukemia virus (M-MuLV) were shown to req
125 as constructed by replacing the U3 region of Moloney murine leukemia virus (M-MuLV) with homologous s
126 r gene inactivation during leukemogenesis by Moloney murine leukemia virus (M-MuLV), a genome-wide sc
127 onacutely transforming retroviruses, such as Moloney murine leukemia virus (M-MuLV), differ from tran
128 human immunodeficiency virus type 1 (HIV-1), Moloney murine leukemia virus (M-MuLV), human T-cell leu
129 n immunodeficiency virus, type 1 (HIV-1) and Moloney murine leukemia virus (M-MuLV), we determined th
130 -1 (human immunodeficiency virus type 1) and Moloney murine leukemia virus (M-MuLV), we evaluated how
137 cently discovered that the NC protein of the Moloney murine leukemia virus (MLV) can bind with high a
139 nalyze more than 40 derivatives of ecotropic Moloney murine leukemia virus (MLV) envelope, containing
140 , retrovirus packaging cell lines expressing Moloney murine leukemia virus (MLV) gag and pol genes pr
141 ion of psi (i.e., leader) sequences from the Moloney murine leukemia virus (MLV) genome into the 3' u
142 racterized the structure and function of the Moloney murine leukemia virus (MLV) IN protein in viral
143 identified as a common integration site for Moloney murine leukemia virus (MLV) in rat thymic lympho
145 ansportin 3 protein under conditions whereby Moloney murine leukemia virus (MLV) integrase failed to
147 linkages, we digested deproteinized RNA from Moloney murine leukemia virus (MLV) particles with RNase
148 ave probed the nucleoprotein organization of Moloney murine leukemia virus (MLV) pre-integration comp
150 n HIV-1-based lentiviral vector to that by a Moloney murine leukemia virus (MLV) retroviral vector, u
151 ups of synthetic RNA-DNA hybrids with either Moloney murine leukemia virus (MLV) RT or human immunode
153 mmaretroviruses, we engineered a fluorescent Moloney murine leukemia virus (MLV) system consisting of
154 purvalanol A, and methoxy-roscovitine, block Moloney murine leukemia virus (MLV) transcription events
155 mo- and heterodimerization were examined for Moloney murine leukemia virus (MLV) using nondenaturing
156 f human hematopoietic stem cells (HSCs) with Moloney murine leukemia virus (MLV) vectors have been an
157 vity, while infection by the gammaretrovirus Moloney murine leukemia virus (MLV) was unaffected.
158 escribe the properties of the Gag protein of Moloney murine leukemia virus (MLV), a gammaretrovirus.
159 n, with functionally homologous regions from Moloney murine leukemia virus (MLV), a murine retrovirus
160 ins from four different retroviruses: HIV-1, Moloney murine leukemia virus (MLV), Rous sarcoma virus
161 file that may be safer than that of standard Moloney murine leukemia virus (MLV)-derived retroviral v
166 retroviral promoters and enhancers from the Moloney Murine Leukemia Virus (MMLV) and the Myeloprolif
169 ed to play a similar preintegrative role for Moloney murine leukemia virus (MMLV) in addition to HIV-
170 ies of the 3' end processing site within the Moloney murine leukemia virus (MMLV) LTR d(TCTTTCATT), a
171 (RT) fidelity, we measured the error rate of Moloney murine leukemia virus (MMLV) RT in the presence
172 s in the pE vectors have been taken from the Moloney murine leukemia virus (MMLV) vector pMFG, which
173 ocytes are refractory to gene transfer using Moloney murine leukemia virus (MMLV)-based retroviral ve
174 ansplantation model, the authors evaluated a Moloney murine leukemia virus (MMLV)-based vector encodi
175 In this report, we made use of a chimeric Moloney murine leukemia virus (MMLV)-HIV-1 Gag in which
176 n JSRV and the unrelated murine retroviruses Moloney murine leukemia virus (MMuLV) and mouse mammary
178 etherin markedly inhibits the replication of Moloney murine leukemia virus (Mo-MLV) and is required f
184 be transgenic mice expressing fusions of the Moloney murine leukemia virus (Mo-MuLV) Gag protein to s
187 nuclear localization signals (NLSs) into the Moloney murine leukemia virus (Mo-MuLV) integrase (IN) p
188 B1/DNMT3A/DNMT3L complex to newly integrated Moloney murine leukemia virus (Mo-MuLV) proviral DNA.
189 ed in which the U3 region of T-lymphomagenic Moloney murine leukemia virus (Mo-MuLV) was replaced by
190 1), simian immunodeficiency virus (SIV), and Moloney murine leukemia virus (Mo-MuLV), for the presenc
194 tion of a novel domain in the Gag protein of Moloney murine leukemia virus (MoLV) that is important f
195 an immunodeficiency virus type I (HIV-1) and Moloney murine leukemia virus (MoMLV) capsid proteins we
197 es, whereas the prototypical gammaretrovirus Moloney murine leukemia virus (MoMLV) favors strong enha
199 1), feline immunodeficiency virus (FIV), and Moloney murine leukemia virus (MoMLV) integrases were st
200 Retroviral reverse transcriptase (RT) of Moloney murine leukemia virus (MoMLV) is expressed in th
201 n factor (BAF) blocks the autointegration of Moloney murine leukemia virus (MoMLV) PICs in vitro.
204 polymerase, but not the RNase H function of Moloney Murine Leukemia Virus (MoMLV) RT and also inhibi
205 ays which show that tetherin does not affect Moloney murine leukemia virus (MoMLV) spread, and only m
206 he HIV-1 vector was also more efficient than Moloney murine leukemia virus (MoMLV) vectors for transd
207 nd particle ultrastructure highly similar to Moloney murine leukemia virus (MoMLV), another gammaretr
208 xamine the early events in the life cycle of Moloney murine leukemia virus (MoMLV), we analyzed the i
209 lope protein (Env) can be used to pseudotype Moloney murine leukemia virus (MoMLV)-based retrovirus v
216 ents for host proteins in the integration of Moloney murine leukemia virus (MoMuLV) cDNA in vitro.
220 Recent studies with small fragments of the Moloney murine leukemia virus (MoMuLV) genome suggested
224 ll surface reporter under the control of the Moloney murine leukemia virus (MoMuLV) long terminal rep
226 n with gibbon-ape leukemia virus pseudotyped Moloney murine leukemia virus (MoMuLV)-based retrovirus
227 ropathogenic temperature-sensitive mutant of Moloney murine leukemia virus (MoMuLV-ts1), results in m
229 rmation from scarce, femtomole quantities of Moloney murine leukemia virus (MuLV) RNA inside authenti
237 irus type 1 nucleocapsid protein and for the moloney murine leukemia virus nucleocapsid zinc knuckle
239 able of producing high titers of recombinant Moloney murine leukemia virus particles that have incorp
242 onine-specific proviral integration site for Moloney murine leukemia virus (PIM) kinases PIM1 and PIM
243 tated sequences both within and flanking the Moloney murine leukemia virus polypurine tract (PPT) and
244 R to probe the nucleoprotein organization of Moloney murine leukemia virus preintegration complexes.
246 e TGF-beta1 under the control of the CMV and Moloney murine leukemia virus promoters significantly in
248 nal structure of the double hairpin from the Moloney murine leukemia virus ([Psi(CD)](2), 132 nt, 42.
250 elops in mice infected with ts1, a mutant of Moloney murine leukemia virus, resembles human AIDS.
252 with ts1, the neuropathogenic mutant of the Moloney murine leukemia virus, results in motor neuronal
253 Inhibitor resistance of several commercial Moloney murine leukemia virus reverse transcriptase (MML
254 an effort to increase the thermostability of Moloney Murine Leukemia Virus reverse transcriptase (MML
255 n which the host, the N-terminal fragment of Moloney murine leukemia virus reverse transcriptase (MML
257 with the Superscript II version of RNase H- Moloney murine leukemia virus reverse transcriptase at 5
258 A resolution of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase comp
261 restored by adding back a truncated form of Moloney murine leukemia virus reverse transcriptase lack
263 ed on the ability of the RNase H activity of Moloney murine leukemia virus reverse transcriptase to c
265 , including D114A and R116A substitutions in Moloney murine leukemia virus reverse transcriptase, are
266 conserved residues in the fingers domain of Moloney murine leukemia virus reverse transcriptase, res
267 member of the highly conserved LPQG motif in Moloney murine leukemia virus reverse transcriptase, we
268 t includes the fingers and palm domains from Moloney murine leukemia virus reverse transcriptase.
269 of mutations affecting the RNase H domain of Moloney murine leukemia virus reverse transcriptase.
270 n of human immunodeficiency virus type 1 and Moloney murine leukemia virus reverse transcriptases wit
271 ng model hybrid substrates and the HIV-1 and Moloney murine leukemia virus reverse transcriptases, we
272 to complete a single round of intracellular Moloney murine leukemia virus reverse transcription appr
273 The first strong stop template switch during Moloney murine leukemia virus reverse transcription was
276 ddition, PARP-1-deficient MEFs infected with Moloney murine leukemia virus showed no decrease in viru
277 1 (fti-1) (feline leukemia virus) and Ahi-1 (Moloney murine leukemia virus) shows that these display
278 transcriptase-associated RNase H activity of Moloney murine leukemia virus specifically cleaves withi
279 ts1 is a temperature-sensitive mutant of Moloney murine leukemia virus that causes hind-limb para
280 he generation of retroviral vectors based on Moloney murine leukemia virus that specifically transduc
281 eviously, we have shown that, in the case of Moloney murine leukemia virus, the U3 region of the LTR
284 ic HTLV-1 with a replaced envelope gene from Moloney murine leukemia virus to allow HTLV-1 to fuse wi
285 substitutions were introduced into the NC of Moloney murine leukemia virus to examine further its rol
287 s on the neurovirulent viruses FrCas(NC) and Moloney murine leukemia virus ts1 indicate that the nasc
288 The recent development of a pseudotyped Moloney murine leukemia virus vector that contains the G
294 ting residues in the nucleocapsid protein of Moloney murine leukemia virus was investigated by introd
295 r-promoter of the 3' long terminal repeat of Moloney murine leukemia virus with a synthetic tetracycl
296 study, we tested replication properties for Moloney murine leukemia viruses with targeted mutations
298 We also determined whether the wild type Moloney murine leukemia virus (wt-MoMuLV) and one of its
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。